NVTA Invitae Corp
Invitae Corp is a genetic information company engaged in genetic diagnostics for hereditary disorders. It provides testing for multiple genes including hereditary cancer, neurological disorders, cardiovascular disorders and other hereditary conditions.
$43.72 +3.59 (8.95%)
As of 03/01/2021 16:00:02 EST IEX book CBOE book
Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Mid cap
Health Care
Diagnostics & Research
USA
USA
02/12/2015
176,699,713
3,911,484
$7,090,959,483
0.00%
SEC Edgar Online
10-Q
10-K
46185L103
US46185L1035
BVVCNT1
Common stocks
Mid cap
Health Care
Diagnostics & Research
USA
USA
02/12/2015
176,699,713
3,911,484
$7,090,959,483
0.00%
SEC Edgar Online
10-Q
10-K
46185L103
US46185L1035
BVVCNT1
Valuation (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
PB ratio:
PS ratio:
Return on equity:
Net income %:
-11.78
3.66
25.36
-30.47%
-215.37%
3.66
25.36
-30.47%
-215.37%